KYMR VS AGTI Stock Comparison

Performance

KYMR
10/100

KYMR returned -38.95% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

AGTI
10/100

AGTI returned -50.03% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Sentiment

KYMR
69/100

KYMR had a bullish sentiment score of 68.98% across Twitter and StockTwits over the last 12 months. It had an average of 2.55 posts, 2.33 comments, and 0.61 likes per day.

AGTI

"Sentiment" not found for AGTI

Technicals

KYMR
75/100

KYMR receives a 75 of 100 based on 14 indicators. 10 are bullish, 3 are bearish.

AGTI
61/100

AGTI receives a 60 of 100 based on 14 indicators. 8 are bullish, 5 are bearish.

Earnings

KYMR
10/100

KYMR has missed earnings 11 times in the last 20 quarters.

AGTI
19/100

AGTI has missed earnings 3 times in the last 20 quarters.

Profit

KYMR
10/100

Out of the last 17 quarters, KYMR has had 0 profitable quarters and has increased their profits year over year on 0 of them.

AGTI
52/100

Out of the last 16 quarters, AGTI has had 9 profitable quarters and has increased their profits year over year on 5 of them.

Volatility

KYMR
47/100

KYMR has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.

AGTI
36/100

AGTI has had a lower than average amount of volatility over the last 12 months giving it a score of 36 of 100.

Dividend

KYMR

"Dividend" not found for KYMR

AGTI
10/100

AGTI's most recent dividend was $0.00 per share, based on a share price of $7.83. It was a payout ratio of 0.00% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Kymera Therapeutics, Inc. Common Stock Summary

Nasdaq / KYMR

Healthcare

Biotechnology

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Agiliti, Inc. Summary

New York Stock Exchange / AGTI

Healthcare

Medical - Healthcare Information Services

Agiliti, Inc., together with its subsidiaries, provides healthcare technology management and service solutions to the healthcare industry in the United States. It offers onsite managed services that are comprehensive programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity. The company also provides clinical engineering services comprising maintenance, repair, and remediation solutions for various types of medical equipment, including general biomedical equipment, diagnostic imaging equipment, and surgical equipment through supplemental and outsourced offerings. In addition, it offers equipment solutions, which primarily provide supplemental, peak need, and per-case rental of general biomedical, specialty, and surgical equipment to acute care hospitals and alternate site providers, including premier healthcare institutions and integrated delivery networks. The company serves acute care hospitals, health systems and integrated delivery networks and alternate site providers Agiliti, Inc. was founded in 1939 and is headquartered in Eden Prairie, Minnesota.

Power up your portfolio